Table of Contents
Beyond Tamoxifen: A New Strategy in Reducing Recurrence
Background
Background
Tamoxifen
Tamoxifen
Study Design
Study Design
Primary Endpoint
Secondary Endpoints
Results
Recurrences of Primary Cancers and New Contralateral Breast Cancers
Discussion
Discussion
Side Effects
Estrogen Deficiency
Questions to be addressed:
Cost
Questions
|
Author: OCHSNER CLINIC FOUNDATION
|